Search
for
Sort by
Research 61–90 of 1000+
- Finasteride: The First 5α-Reductase Inhibitor
- A Slippery Preventive Slope
- Interactions between Lower Urinary Tract Symptoms and Cardiovascular Risk Factors Determine Distinct Patterns of Erectile Dysfunction: A Latent Class Analysis
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Redefining hormone resistance in prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Slow progress in prostate cancer
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- High-throughput and direct measurement of androgen levels using turbulent flow chromatography liquid chromatography-triple quadrupole mass spectrometry (TFC-LC-TQMS) to discover chemicals that modulate dihydrotestosterone production in human prostate cancer cells
- Prostate Cancer Early Detection, Version 2.2015
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Male pattern baldness and incidence of prostate cancer
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Association between male pattern baldness and prostate disease: A meta-analysis
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Male pattern baldness and prostate cancer risk in a population-based case–control study